Gonadotrophin secretion in vitro by cells of a pituitary tumour from a patient with multiple endocrine neoplasia type I

Clinical Endocrinology

Volumn 36, Issue 5, 1992, Pages 475-480

  Daniels, M ^a   Newland, P ^a   Dewar, J H ^b   White, M C ^a   Kendall Taylor P ^a  

^a Department of Medicine ^*  (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CORTICOTROPIN; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; PROTIRELIN; TESTOSTERONE; TETRACOSACTIDE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOPHYSIS TUMOR; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL;

ADENOMA, CHROMOPHOBE; CASE REPORT; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HUMAN; LUTEINIZING HORMONE; MALE; MIDDLE AGE; MULTIPLE ENDOCRINE NEOPLASIA; PITUITARY NEOPLASMS; RADIOIMMUNOASSAY; SECRETORY RATE; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0026573813     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.1992.tb02248.x     Document Type: Article

References (27)

1. Hormone secretion by dispersed cell cultures of human pituitary adenomas: effects of theophylline, thyrotropin‐releasing hormone, somato‐statin, and 2‐bromo‐α‐ergocriptine
2. Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas
3. Linkage analysis of multiple endocrine neoplasia type I with INT 2 and other markers on chromosome 11
4. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type I
5. Familial multiple endocrine adenoma‐peptic ulcer complex
6. Hormone production in clinically nonfunctioning pituitary adenomas
7. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type I
8. Familial multiple endocrine neoplasia type I: a new look at pathophysiology
9. 6]GnRH(1–9)nonapeptide‐ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro
10. Prolactinomas as part of the multiple endocrine neoplastic syndrome type I
11. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas
12. Multiple endocrine neoplasia type I gene maps to chromosome 11 and is lost in insulinoma
13. Secretion of neuron‐specific enolase, prolactin, growth hormone, luteinising hormone and follicle stimulating hormone by ‘functionless’ and endocrine‐active pituitary tumours in vitro
14. Quantitative in‐situ hybridization histochemistry of anterior pituitary hormone mRNA species in human pituitary adenomas
15. Secretion of LH, FSH and PRL shown by cell culture and immunocytochemistry of human functionless pituitary adenomas
16. Immunohistological studies on clinically silent pituitary adenomas
17. Culture of human pituitary prolactin and growth hormone cells
18. Abnormal secretion of glycoprotein α‐subunit and follicle‐stimulating hormone (FSH) β‐subunit in men with pituitary adenomas and FSH hyper‐secretion
19. Gonadotroph cell adenomas of the pituitary
20. Gonadotrophin and alpha subunit secretion by ‘functionless’ pituitary adenomas in cell culture: long term effects of luteinizing hormone releasing hormone and thyrotropin releasing hormone
21. Multiple endocrine neoplasia
22. Association of parathyroid tumors in multiple endocrine neoplasia type I with loss of alleles on chromosome 11
23. Genetic aspects of adenomatosis of endocrine glands
24. Effects of growth hormone‐releasing factor (1–44) on growth hormone release from human somatotrophinomas in vitro: interaction with somatostatin, dopamine, vasoactive intestinal peptide and cycloheximide
25. Growth hormone secreting pituitary adenomas are heterogeneous in culture and commonly secrete glycoprotein hormone α‐subunit
26. LH and FSH secretion and responses to GnRH and TRH in patients with clinically functionless pituitary adenomas
27. Multiple endocrine neoplasia type I